FindTrial
Sign In

LY2605541

DRUG17 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy VolunteersHepatic InsufficiencyType 1 Diabetes Mellitus

Phase 1

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar
CompletedNCT01654380
Eli Lilly and CompanyDiabetes Mellitus, Type 1, Healthy Volunteers
Start: 2012-07-31End: 2013-10-31Updated: 2019-03-08
A Single Dose Study of LY2605541 in Participants With Liver Impairment
CompletedNCT01751399
Eli Lilly and CompanyDiabetes Mellitus, Type 2, Healthy Volunteers, Hepatic Insufficiency
Start: 2012-12-31End: 2013-09-30Updated: 2018-10-19
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
CompletedNCT01769404
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2013-02-28End: 2013-12-31Updated: 2019-06-24
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes
CompletedNCT01784211
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2013-02-28End: 2013-11-30Updated: 2019-03-15
A Study of LY2605541 in Healthy Participants and in the Elderly
CompletedNCT01818245
Eli Lilly and CompanyHealthy Volunteers
Start: 2013-03-31End: 2013-07-31Updated: 2018-10-16
A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants
CompletedNCT01871493
Eli Lilly and CompanyHealthy Volunteers
Start: 2013-06-30End: 2013-09-30Target: 40Updated: 2014-10-21
A Study of LY2605541 in Healthy Participants
CompletedNCT01877265
Eli Lilly and CompanyHealthy Volunteers
Start: 2013-06-30End: 2013-09-30Updated: 2018-10-19
A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics
CompletedNCT01925989
Eli Lilly and CompanyType 1 Diabetes Mellitus
Start: 2013-11-30End: 2015-10-31Updated: 2019-03-01

Phase 2

A Study for Patients With Type 2 Diabetes
CompletedNCT01027871
Eli Lilly and CompanyDiabetes Mellitus, Type 2
Start: 2010-01-31End: 2011-01-31Updated: 2018-06-08
A Study for Patients With Type 1 Diabetes
CompletedNCT01049412
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2010-01-31End: 2011-01-31Updated: 2018-04-17

Phase 3

A Study in Patients With Type 2 Diabetes Mellitus
CompletedNCT01435616
Eli Lilly and CompanyDiabetes Mellitus, Type 2
Start: 2011-11-30End: 2014-01-31Updated: 2018-04-13
A Study in Participants With Type I Diabetes Mellitus
CompletedNCT01454284
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2012-01-31End: 2014-02-28Updated: 2018-04-17
A Study in Participants With Type 2 Diabetes Mellitus
CompletedNCT01468987
Eli Lilly and CompanyDiabetes Mellitus, Type 2
Start: 2011-12-31End: 2013-08-31Updated: 2018-04-17
A Study in Participants With Type 1 Diabetes Mellitus
CompletedNCT01481779
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2012-01-31End: 2014-06-30Updated: 2018-04-17
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
CompletedNCT01582451
Eli Lilly and CompanyDiabetes Mellitus, Type 2
Start: 2012-05-31End: 2013-12-31Updated: 2018-04-20
A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes
CompletedNCT01790438
Eli Lilly and CompanyDiabetes Mellitus, Type 2
Start: 2013-03-31End: 2014-05-31Updated: 2018-05-03
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
CompletedNCT01792284
Eli Lilly and CompanyType 1 Diabetes Mellitus
Start: 2013-02-28End: 2014-04-30Updated: 2018-04-20

Related Papers

Accurate Collection of Reasons for Treatment Discontinuation to Better Define Estimands in Clinical Trials.
2022-12-212 citations
Cytokeratin-18 and Enhanced Liver Fibrosis Scores in Type 1 and Type 2 Diabetes and Effects of Two Different Insulins
Journal of Investigative Medicine2017-11-234 citations
The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.
2017-06-064 citations